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Abstract
For Genetic Analysis Workshop 15 Problem 2, we organized data from several ongoing studies designed to identify
genetic and environmental risk factors for rheumatoid arthritis. Data were derived from the North American
Rheumatoid Arthritis Consortium (NARAC), collaboration among Canadian researchers, the European Consortium on
Rheumatoid Arthritis Families (ECRAF), and investigators from Manchester, England. All groups used a common standard
for defining rheumatoid arthritis, but NARAC also further selected for a more severe phenotype in the probands.
Genotyping and family structures for microsatellite-based linkage analysis were provided from all centers. In addition, all
centers but ECRAF have genotyped families for linkage analysis using SNPs and these data were additionally provided.
NARAC also had additional data from a dense genotyping analysis of a region of chromosome 18 and results from
candidate gene studies, which were provided. Finally, smoking influences risk for rheumatoid arthritis, and data were
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provided from the NARAC study on this behavior as well as some additional phenotypes measuring severity. Several
questions could be evaluated using the data that were provided. These include comparing linkage analysis using single-
nucleotide polymorphisms versus microsatellites and identifying credible regions of linkage outside the HLA region on
chromosome 6p13, which has been extensively documented; evaluating the joint effects of smoking with genetic factors;
and identifying more homogenous subsets of families for whom genetic susceptibility might be stronger, so that linkage
and association studies may be more efficiently conducted.
Background
Rheumatoid arthritis (RA) is a complex disease with a
moderately strong genetic component. The recurrence risk
ratio for siblings is typically estimated at around six in
Caucasians, but with a broad range of values, primarily
because the prevalence in the population is not well char-
acterized [1]. The prevalence also varies among popula-
tions, ranging from around 0.8% in Caucasians to 10% in
some Native American groups, although it is not clear that
this is always the same phenotype. RA appears to be rare
in rural African populations. Generally females are at
higher risk than males, with about a three to one prepon-
derance of females to males. The mean age of disease
onset is in the fifth decade, with considerable variability
in age at presentation, including occasional presentation
in the teenage years.
The HLA region on 6p21 has been implicated by numer-
ous studies, and there is consistent evidence that DR alle-
les contribute to disease risk. The 'shared epitope'
hypothesis was proposed by Gregersen et al. [2] to explain
the organization of risk for rheumatoid arthritis from DR
alleles. According to this hypothesis, individuals who
share a QK/RRAA motif in positions 70 to 74 of the DR
molecule show an increased risk for disease. The alleles
that confer increased risk for rheumatoid arthritis include
DRB1*0101, 0102, 0104, 0105, 0401, 0404, 0405, 0408,
0409, 1001, 1402, and 1406, with highest risk alleles
being bolded [3]. This model was not quite sufficient to
explain risk according to DR types and a newer model uti-
lizing data from positions 70 to 74 has been developed
[4]. Aside from these main effects, there is also evidence
for an interaction or haplotypic effects including the class
I region and the central MHC, along with certain DR alle-
les, notably DR3 [5,6].
Specific autoantibodies are noted to co-occur with rheu-
matoid arthritis. Rheumatoid factor (RF) IgM is a measure
of active disease correlated with erosive arthritic disease.
However, a more newly identified autoantibody, anti-
cyclic citrullinated peptide (anti-CCP), is more specific for
the disease and is a better predictor of erosive outcome
[7]. Elevations of anti-CCP have been noted to predict
increased risk for development of rheumatoid arthritis
[8]. The shared epitope alleles are strongly associated with
the presence of anti-CCP antibodies, and this effect is
modulated by HLA-DR3 [7]. Alleles at the PTPN22 locus
have been shown to confer an increased risk for RA [9]. At
least two alleles of PTPN22 have been implicated as caus-
ing increased risk for RA; with the R620W allele in
rs2476601 (hCV16021387) conferring 1.7- to 1.9-fold
increased risk to heterozygotes and higher risks to
homozygous carriers. Increased risk was also noted for
either hCV8689108 or hCV25762283 [10], with some
indeterminacy because of linkage disequilibrium among
these markers (and others in the region). These findings
have further been confirmed by analysis of transmission
of PTPN22 alleles to affected offspring in families [11].
Additional loci that have been implicated include PADI4,
which encodes the enzyme catalyzing citrullination in
macrophages (on chromosome 1p), intron 1 of SLC22A4
on chromosome 5q, RUNX1 (on chromosome 1q), and a
locus on chromosome 17 possibly predisposing to psoria-
sis. Marker data for these other loci could not be obtained,
but have generally not shown consistent increases in risk
for Caucasian populations. The CTLA4 locus on chromo-
some 4p has been associated with mildly increased risk for
rheumatoid arthritis [12].
Aside from identified genetic factors and sex, few environ-
mental cofactors have yet been identified as affecting risk
for rheumatoid arthritis. However, current smoking con-
fers about a two-fold increased risk [13]. Klareskog et al.
[14] recently showed that the risk from smoking for rheu-
matoid arthritis is particularly high among individuals
who have a shared epitope allele and who also have ele-
vated levels of anti-CCP. The biological basis for this
rather complex interaction appears to reflect increased cit-
rullination of peptides among smokers, and presentation
of citrullinated peptides by shared epitope alleles.
The primary goal of the studies that were submitted for
the Genetic Analysis Workshop 15 has been to identify
genetic factors that predispose for rheumatoid arthritis.
Four independent academic groups and one company
have provided data for the workshop. In addition, given
some previously identified evidence for effects of smoking
on rheumatoid arthritis risk and difference in risk accord-
ing to gender, there is considerable interest in identify
gene × environment and gene × gene combinations thatBMC Proceedings 2007, 1(Suppl 1):S3 http://www.biomedcentral.com/1753-6561/1/S1/S3
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yield particularly high risks to individuals for rheumatoid
arthritis.
Methods
Data for the workshops were provided by five centers. Two
centers (Canada and NARAC) had SNP genotyping per-
formed jointly. The data were transmitted from each
center to the University of Texas M.D. Anderson Cancer
Center, where the data sets were checked to assure the
availability of data definitions and to evaluate the format-
ting and completeness of the data transfer. Subsequently,
data were transmitted to the Southwest Foundation for
Biomedical Research for integration and transfer to
GAW15 participants. Questions about data integrity or
meaning were transmitted to the University of Texas M.D.
Anderson Cancer Center, which then interacted with the
data providers to obtain answers. All affected subjects in
all of the studies met the standard ACR criteria for affec-
tion with rheumatoid arthritis [15]. A distribution of
selected clinical characteristics among study participants
is provided in Table 1.
The North American Rheumatoid Arthritis Consortium 
study (NARAC)
Microsatellite scans
The familial clustering patterns, association with extra-
articular findings, and correlation in ages of onset in most
of the NARAC collection have been described by Jawaheer
et al. [16]. Affected subjects did not have other autoim-
mune diseases that include an arthritic component such
as systemic lupus erythematosis, Crohn's disease, or pso-
riasis. NARAC has performed microsatellite scans [17]
using the Applied Biosystems, Inc. (ABI) standard panels
for 511 multiplex families that include 676 sib pairs (and
parents were available) as well as a handful of somewhat
larger families. About 90% of the families are Caucasian.
The Kong and Cox LOD score for chromosome 6p is
approximately 17 and extends rather centromerically, sug-
gesting a possible second locus on 6p [18].
SNP scans
Illumina performed analysis of about 5600 genome-wide
SNPs on all families including 66 families from Katherine
Siminovitch, a collaborator in Canada. Results of the
analysis of the NARAC Caucasian families were published
and indicate previously unreported linkages on chromo-
somes 2, 4, and 11 along with the known linkage on chro-
mosome 6p [18].
Association mapping
A dense panel of 2719 SNPs were genotyped by Illumina
for an approximately 10-kb region of chromosome 18q
that showed evidence for linkage in the U.S. and French
linkage scans. Of these, 2300 met quality control criteria
and have been retained and distributed for analysis. These
markers were individually genotyped on 460 cases and
460 controls. Controls were recruited from a New York
City population and cases have been recruited from mul-
tiple U.S. centers. As a part of the data release process, we
also distributed the estimated Northern versus Southern
European ancestry of cases and controls [19] because the
European ancestry of cases and controls deviates, given
different catchements for cases versus controls.
Quantitative phenotypes
Two quantitative phenotypes that are used for identifying
RA-affected individuals include anti-CCP and RF-IgM. The
heritability of these measures is hard to obtain from the
selected sib pairs we are studying. After proband correc-
tion, the heritability estimates are 11% and 30%; before
Table 1: Distribution of selected clinical characteristics among study participants from rheumatoid arthritis studies for GAW15 
Problem 2
Study source US Microsa US-SNPsb Canada 
Affymetrix
Canada 
Illuminac
France UK Cohort 1d UK Cohort 2e
Ascertainment criteria 2 ACR+ sibs, 1 
with erosions
2 ACR+ sibs, 1 
with erosions
2 ACR+ sibs 2 ACR+ sibs 2 ACR+ sibs 2 ACR+ sibs
Number of families 511 757 79 60 88 174 195
Affected sibs/family 2.13 2.15 2 2 2.18 2.13 2.09
% SE+ 71% 79% N/A N/A N/A 90% 82%
% Erosion 95% 97% 39% N/A N/A 76% 71%
Median age onset 39.1 38.9 43.8 N/A N/A 39.3 44.0
% RF+ 81.1% 74.3% 71.1% N/A N/A 62.5% 56.7%
aNumbers from Jawaheer et al. [17]. One family was eliminated from GAW15 data because one sib did not meet ACR criteria for RA.
bOf these families, 9 had only phenotype information and no SNP genotypes, 509 families have both SNP and microsatellite data, 2 families have 
microsatellite data only, and 237 have SNP data only.
c47 families have genotype data using both Affymetrix and Illumina platforms.
d174 affected families had microsatellite data and of these 157 also had SNP genotyping.
eSelected microsatellite markers were genotyped for variable numbers of these families.BMC Proceedings 2007, 1(Suppl 1):S3 http://www.biomedcentral.com/1753-6561/1/S1/S3
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correction the heritabilities are 15% and 67%. Linkage
analysis of Rf-IgM and anti-CCP phenotypes with micro-
sattelites [20] showed strong evidence for linkages of
these phenotypes to chromosome 6 and LOD scores over
1 for linkage of both phenotypes to 1p21.1, 5q15, 8p23.1,
16p12.1, 16q23.1, and 18q21.31.
Clinical measures
Clinical measures that are available include age at onset,
sex, ethnicity, presence of erosions, and duration of dis-
ease. Data were also provided concerning the physician-
reported severity of disease (JAM scores) as well as the
patient's functional status (HAQ scores). Smoking
increases risk for rheumatoid arthritis, and limited smok-
ing data are available for families and controls. Digitized
hand radiographs are available on the NARAC website.
The currently available X-ray scores were derived by a sin-
gle radiologist at the Bethesda Naval Medical Center.
Jawaheer et al. studied clinical characteristics of the study
subjects [13].
The European Consortium on Rheumatoid Arthritis 
Families (ECRAF)
ECRAF provided high-density microsatellite data from 88
families, including 75 affected sib pairs, 12 affected sib
trios, and 1 affected sib quaternion typed with 1089 mic-
rosatellite markers [21]. PTPN22 genotypes are available
from this collection. All affected subjects from this study
met ACR criteria [16].
United Kingdom – Manchester
The UK group led by Jane Worthington and Sally John
provided data from analysis of 10,156 SNP markers that
were genotyped and passed quality control filters on 157
families [22]. In addition microsatellite data from an
entire genome-wide screen was available from 369 mark-
ers that were genotyped on 174 families (screen 1) with
two or more affected siblings and from 10 candidate
regions that showed evidence in screen 1 for linkage gen-
otyped for 89 markers on a different set of 195 families
with two or more affected siblings [23]. All affected indi-
viduals have been classified as affected according to ACR
criteria [16].
Canada – Toronto
The Canadian group, led by Katherine Siminovitch, pro-
vided 60 families that have been genotyped using the Illu-
mina platform used by NARAC (performed at the same
time as the NARAC study) as well as 79 families (one sib
pair had only one affected sibling and is excluded from
tabulations) that were genotyped using an Affymetrix 100
K platform. Patients (n = 86) were recruited from large
clinical populations in the Toronto area in collaboration
with academic-based rheumatologists. Sibships with
affected pairs were also recruited from academic centers in
Nova Scotia (n  = 72). All affected patients met 1987
revised criteria for RA [16]. The presence of other diseases
that are accompanied by inflammatory arthritis, such as
psoriasis or inflammatory bowel disease, was an exclu-
sionary criterion for families. Informed consent was
obtained from every subject, including all participating
family members, and approval of the local institutional
review board was secured at every recruitment site prior to
enrollment. Of the families studied, 76 were European
Caucasian, 1 was Indian, 1 was South-East Asian, and 1
was Ashkenazic. The median time to onset with RA was 42
years of age, 25% of cases were male, and 37% had ero-
sions.
Discussion
Although previous research has identified a few loci that
consistently show association with rheumatoid arthritis, a
great deal remains unknown about the mechanisms by
which genetic factors interrelate to increase disease risk,
and the impact that environmental factors such as smok-
ing behavior have upon disease risk. The collaborative
approach that has been adopted by rheumatoid arthritis
researchers provided an excellent platform for integrating
data from multiple sites in an effort to obtain a larger and
more powerful collection of data resources than was pos-
sible from a single site. In addition, the Genetic Analysis
Workshop platform allowed the data to be more thor-
oughly and impartially queried than is possible by any of
the single collaborating sites. The following sets of ques-
tions were posed to the GAW participants:
1. When analyzing dense SNP data and when parental
data are missing what is the best procedure for dealing
with linkage disequilibrium? We have noted some very
high LOD scores in both the Canadian and NARAC data
sets that can be eliminated by removing excess LD, but
does this lead to an excess loss of information?
2. How best to analyze data from the pseudo-autosomal
region?
3. Is there evidence for gene × environment interactions?
Do PTPN22 and the shared epitope interact with smoking
behavior to increase risk for disease? Can subgroups with
very high risk for disease be identified? (Note this may not
be the best data set to answer this question.) Does smok-
ing influence severity or age to onset of disease? What are
the best procedures for using known covariates such as
sex, anti-CCP levels, and shared epitope status to identify
genetic loci influencing disease susceptibility?
4. Do the quantitative variables provide any increased
power to identify genetic loci? Although microsatellite
data have been analyzed for the quantitative traits, at this
time the SNP data have not yet been analyzed.BMC Proceedings 2007, 1(Suppl 1):S3 http://www.biomedcentral.com/1753-6561/1/S1/S3
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5. Meta-analysis: What are the best ways to combine data
across the studies? Is there any strong evidence for gene ×
gene interactions? Is there more than one locus on chro-
mosome 6 influencing disease risk? Can the PTPN22
locus on chromosome 1 be identified by linkage?
6. Association data: Are there any loci on chromosome 18
that reliably predict disease risk? Are there any subsets
with particularly high risks for disease?
Conclusion
The data that were provided is composed largely of
affected sib-pairs. Efforts were made to collect extended
relatives when they were available. However, the aggrega-
tion of rheumatoid arthritis in families usually occurs in
siblings and parents of the proband and only rarely occurs
in extended pedigrees. Due to fiscal constraints, only a few
of the families from NARAC included unaffected relatives,
and none of the other sites provided data from unaffected
relatives. A variety of methods are required to unravel the
complex genetic and environmental interactions that
cause this complex disease. The value of the genetic anal-
ysis workshop has been that it brings together analysts
with a wide variety of skills and approaches. The data pro-
viders were thankful for the opportunity to have the exten-
sive data that have been developed and studied in detail
by a wide range of analysts.
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